comparemela.com

Latest Breaking News On - Johan neyts - Page 2 : comparemela.com

Dr Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company. Last month,

Region flamandeAckermans van haarenJohan neytsJeanne bolgerHanne callewaertKai dallmeierHealthcare pharmaceuticals industryKu leuven rega instituteEurope venture fundKu leuven gemma frisius fundV bio venturesAstrivax boardRega instituteProfessor johan neytsFlanders future techfundThuja capital

Dr Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.Last month, AstriVax closed its funding round - led by

Region flamandeAckermans van haarenKostenloser wertpapierhandelJohan neytsJeanne bolgerHanne callewaertKai dallmeierKu leuven rega instituteV bio venturesAstrivax boardRega instituteProfessor johan neytsFlanders future techfundThuja capital

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Region flamandeShelley margetsonJohan neyts ku leuvenFlanders futuretechfundKu leuven gemmafrisiusfundJohan neytsHaasrode leuvenCaroline goddeerisHanne callewaertAckermans van haarenParibas fortisKai dallmeierEuropean life sciencesEuropean union under horizonEuropean investment fundEuropean fund for strategic investments

KU Leuven spin-off AstriVax raises €30M for vaccine platform

The Belgian university spinoff AstriVax has generated the biggest seed capital financing in the institution’s history.

Ackermans van haarenJohan neytsHaasrode leuvenHanne callewaertKai dallmeierKu leuven rega instituteEurope venture fundKu leuven gemma frisius fundRega instituteV bio venturesFlanders future techfundThuja capitalEquity partnersVenture fundFortis private equityGemma frisius

AstriVax Raises €30M in Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Ackermans van haarenPhilippe swiggersJohan neytsHaasrode leuvenPhilippe swiggers hanne callewaertHanne callewaertKai dallmeierKu leuven rega instituteEurope venture fundKu leuven gemma frisius fundV bio venturesFlanders future techfundThuja capitalEquity partnersVenture fundFortis private equity

vimarsana © 2020. All Rights Reserved.